This eBook from ACROBiosystems offers a comprehensive look at the company's end-to-end solution portfolio for antibody-drug conjugate (ADC) development, from early discovery through preclinical and clinical stages.
Inside, you’ll find tools for every step of the workflow, including antibody screening, rapid and site-specific conjugation, internalization mechanism studies, Fc effector function validation, linker screening, and PK analysis. The guide features high-quality target proteins, advanced conjugation kits, pH-sensitive internalization reagents, Fc receptor validation platforms, and bioanalytical antibodies, all of which are designed to support efficient, consistent, and regulatory-ready development.
Download your copy of the eBook to see how ACROBiosystems’ integrated ADC solutions can help de-risk your program and keep development moving smoothly across the pipeline.
About ACROBiosystems
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Their mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. They supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, ACROBiosystems delivers solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. ACROBiosystems empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.